QUQ-11148-41799
3 vaccinations
4 coded responses
39 check-ins
4 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 316 / GA
- Registered
- 2020-12-29
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-29
Registered in v-safe
-
2020-12-30
Dose 1 — Moderna
- 2020-12-30
-
2020-12-31
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness, NauseaAdult check-in
- 2021-01-01
- 2021-01-02
- 2021-01-03
- 2021-01-04
- 2021-01-06
- 2021-01-13
- 2021-01-21
-
2021-01-27
Dose 2 — Moderna
- 2021-01-27
-
2021-01-28
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
- 2021-01-29
- 2021-01-30
- 2021-01-31
- 2021-02-01
- 2021-02-02
- 2021-02-03
- 2021-02-10
- 2021-02-17
- 2021-03-03
- 2021-03-10
-
2021-04-28
Survey response — 3 months, dose 2MedDRA: Menstrual disorder, Menstruation delayed, Premenstrual syndrome — Feeling: FairFree text: Worsening in PMS and delay in cycleMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-07-28
-
2022-01-05
Dose 3 — Moderna
- 2022-01-05
-
2022-01-06
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain, Redness, Swelling, Itching · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2022-01-07
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2022-01-08
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain, Redness, Swelling, Itching · HeadacheAdult check-in
-
2022-01-09
Survey response — days 1–6 daily, dose 3MedDRA: Dyspnoea — Feeling: Good · Site: Pain, Redness, SwellingFree text: Shortness of breathMedDRA releases: 2024-11 · check-in free text available
-
2022-01-10
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Redness, Swelling · NoneAdult check-in
- 2022-01-11
- 2022-01-14
- 2022-01-21
- 2022-01-26
- 2022-02-02
- 2022-02-09
- 2022-02-16
-
2022-04-06
Survey response — 3 months, dose 3MedDRA: Upper respiratory tract infection — Feeling: Poor · Be unable to do your normal daily activitiesFree text: Upper respiratory infectionMedDRA releases: 2024-11 · check-in free text available
-
2022-07-08
Survey response — 6 months, dose 3MedDRA: Cough, Nasopharyngitis, Respiratory tract congestion — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Cold symptoms- cough, congestion.MedDRA releases: 2024-11 · check-in free text available
- 2023-01-05
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-30 | Moderna | |
| 2 | 2021-01-27 | Moderna | |
| 3 | 2022-01-05 | Moderna | No |
Free text
Release 8 — 3 months, dose 2
Symptoms: Worsening in PMS and delay in cycle
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Shortness of breath
Release 11 — 3 months, dose 3
Symptoms: Upper respiratory infection
Release 12 — 6 months, dose 3
Symptoms: Cold symptoms- cough, congestion.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Menstrual disorder | ✓ | ✓ | ○ |
| SD | Menstruation delayed | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Premenstrual syndrome | ✓ | ✓ | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Upper respiratory tract infection | · | · | ✓ |
| SRO | Dyspnoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release